InspireMD, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Arnold Kathryn | — | Award / Grant | 55,556 | — | — | 303,087 | Dec 30, 2025 |
| Stuka Paul | — | Purchase | 5,073 | $1.81 | $9,182 | 391,628 | Dec 9, 2025 |
| Stuka Paul | — | Purchase | 5,073 | $1.86 | $9,436 | 388,918 | Dec 5, 2025 |
| Stuka Paul | — | Purchase | 10,130 | $1.85 | $18,741 | 383,845 | Dec 4, 2025 |
| Stuka Paul | — | Purchase | 13,431 | $1.62 | $21,758 | 373,715 | Nov 12, 2025 |
| ROUBIN GARY S | — | Award / Grant | 48,000 | — | — | 656,425 | Oct 7, 2025 |
| Kester Thomas J | — | Award / Grant | 37,815 | — | — | 458,573 | Sep 15, 2025 |
| ROUBIN GARY S | — | Purchase | 41,322 | $2.42 | $99,999 | 608,425 | Jul 30, 2025 |
| Kester Thomas J | — | Purchase | 30,991 | $2.42 | $74,998 | 420,758 | Jul 30, 2025 |
| Slosman Marvin | CEO and President | Purchase | 10,330 | $2.42 | $24,999 | 2,420,866 | Jul 30, 2025 |
| Stuka Paul | — | Purchase | 20,661 | $2.42 | $50,000 | 444,195 | Jul 30, 2025 |
| Kester Thomas J | — | X | 30,624 | $1.38 | $42,261 | 389,767 | Jul 11, 2025 |
| Stuka Paul | — | X | 87,500 | $1.38 | $120,750 | 423,534 | Jul 1, 2025 |
| BERMAN MICHAEL | — | X | 61,248 | $1.38 | $84,522 | 244,994 | Jun 29, 2025 |
| ROUBIN GARY S | — | X | 30,624 | $1.38 | $42,261 | 567,103 | Jun 25, 2025 |
| Stuka Paul | — | Award / Grant | 48,736 | — | — | 360,284 | Jan 7, 2025 |
| Shore Craig | CFO and CAO | Award / Grant | 232,616 | — | — | 1,112,460 | Jan 7, 2025 |
| Arnold Kathryn | — | Award / Grant | 32,491 | — | — | 247,531 | Jan 7, 2025 |
| Gleason Shane Thomas | Chief Commercial Officer | Award / Grant | 232,616 | — | — | 746,981 | Jan 7, 2025 |
| Kester Thomas J | — | Award / Grant | 32,491 | — | — | 359,143 | Jan 7, 2025 |
| Slosman Marvin | CEO and President | Award / Grant | 558,417 | — | — | 2,410,536 | Jan 7, 2025 |
| Verta Patrick | EVP Clinical/Medical Affairs | Award / Grant | 83,072 | — | — | 311,532 | Jan 7, 2025 |
| BERMAN MICHAEL | — | Award / Grant | 32,491 | — | — | 264,533 | Jan 7, 2025 |
| ROUBIN GARY S | — | Award / Grant | 32,491 | — | — | 534,279 | Jan 7, 2025 |
| Tommasoli Andrea | Chief Operating Officer | Award / Grant | 232,616 | — | — | 727,694 | Jan 7, 2025 |
| Ward Scott R. | — | Award / Grant | 16,245 | — | — | 59,793 | Jan 7, 2025 |
| BERMAN MICHAEL | — | X | 61,249 | $1.38 | $84,524 | 183,746 | Jun 24, 2024 |
| Stuka Paul | — | X | 87,500 | $1.38 | $120,750 | 336,034 | Jun 5, 2024 |
| ROUBIN GARY S | — | X | 30,625 | $1.38 | $42,263 | 501,788 | May 28, 2024 |
| Kester Thomas J | — | X | 30,625 | $1.38 | $42,263 | 326,652 | May 28, 2024 |
| Tommasoli Andrea | Chief Operating Officer | Award / Grant | 238,625 | — | — | 495,078 | Jan 23, 2024 |
| Stuka Paul | — | Award / Grant | 43,548 | — | — | 311,548 | Jan 23, 2024 |
| Verta Patrick | EVP Clinical/Medical Affairs | Award / Grant | 85,720 | — | — | 228,460 | Jan 23, 2024 |
| Shore Craig | CFO and CAO | Award / Grant | 238,625 | — | — | 879,844 | Jan 23, 2024 |
| Kester Thomas J | — | Award / Grant | 29,032 | — | — | 296,075 | Jan 23, 2024 |
| Gleason Shane Thomas | Chief Commercial Officer | Award / Grant | 238,625 | — | — | 514,365 | Jan 23, 2024 |
| ROUBIN GARY S | — | Award / Grant | 29,032 | — | — | 471,163 | Jan 23, 2024 |
| BERMAN MICHAEL | — | Award / Grant | 29,032 | — | — | 232,042 | Jan 23, 2024 |
| Arnold Kathryn | — | Award / Grant | 29,032 | — | — | 215,040 | Jan 23, 2024 |
| Slosman Marvin | CEO and President | Award / Grant | 563,499 | — | — | 1,852,119 | Jan 23, 2024 |
| Kester Thomas J | — | Award / Grant | 3,183 | — | — | 267,043 | Jan 2, 2024 |
| ROUBIN GARY S | — | Award / Grant | 3,229 | — | — | 442,131 | Jan 2, 2024 |
| BERMAN MICHAEL | — | Award / Grant | 3,782 | — | — | 203,010 | Jan 2, 2024 |
| Arnold Kathryn | — | Award / Grant | 1,661 | — | — | 186,008 | Jan 2, 2024 |
| ROUBIN GARY S | — | Purchase | 50,000 | $2.53 | $126,500 | 438,902 | Nov 30, 2023 |
| BERMAN MICHAEL | — | Award / Grant | 3,106 | — | — | 199,228 | Oct 2, 2023 |
| Kester Thomas J | — | Award / Grant | 2,614 | — | — | 263,860 | Oct 2, 2023 |
| Arnold Kathryn | — | Award / Grant | 1,364 | — | — | 184,347 | Oct 2, 2023 |
| ROUBIN GARY S | — | Award / Grant | 2,652 | — | — | 388,902 | Oct 2, 2023 |
| Gleason Shane Thomas | Chief Commercial Officer | Award / Grant | 19,290 | — | — | 275,740 | Aug 28, 2023 |